76
Views
0
CrossRef citations to date
0
Altmetric
Review

Is SjöGren’s Syndrome a Cause for Dry Eyes and Dry Mouth in the Elderly?

Pages 535-549 | Published online: 21 Jul 2009

Bibliography

  • Centers for Disease Control and Prevention. Trends in aging: United States and worldwide. MMWR Morb. Mortal. Wkly. Rep.52, 101–104(2003).
  • Kristine NP , Isenberg, David A: Sjogren‘s syndrome: diagnosis and therapeutic challenges in the elderly. Drugs Aging25(1), 19–33(2008).
  • Ramos-Casals M , García-CarrascoM, BritoP, López-SotoA, FontJ: Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly.Lupus12(5), 341–355(2003).
  • Lazaro D : Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment.Drugs Aging24(9), 701–715(2007).
  • Närhi TO : Prevalence of subjective feelings of dry mouth in the elderly.J. Dent. Res.73(1), 20–25(1994).
  • Whaley K , WilliamsonJ, WilsonTet al.: Sjögren‘s syndrome and autoimmunity in a geriatric population.Age Aging1, 197–206(1972).
  • Chisholm DM , WaterhouseJP, MasonDK: Lymphocytic sialadenitis in the major and minor salivary glands: correlation in post-mortem subjectsJ. Clin. Path.23, 690–694(1970).
  • De Rötth A : On the hypofunction of the lacrimal gland.Am. J. Ophthalmol.24, 20–25(1941).
  • Henderson JW , ProughWA: Influence of age and sex on flow of tears.Arch. Ophthalmol.43(2), 224–231(1950).
  • Wright C , MegerGE: A review of the Schirmer test for tear production.Arch. Ophthalmol.67, 564–565(1962).
  • Norn MS : Tear secretion in normal eyes.Acta Ophthalmol.43, 567–573(1965).
  • Longman LP , HighamSM, RaiKet al.: Salivary gland hypofunction in elderly patients attending a xerostomia clinic.Gerodontology12, 67–72(1995).
  • Anaya J -M, Talal N: Sjögren‘s syndrome and connective tissue diseases associated with other immunologic disorders. In: Arthritis and Allied Conditions (13th Edition). Williams and Wilkins, PA, USA 1561–1580(1997).
  • Diep JT , GorevicPD: Geriatric autoimmune diseases: systemic lupus erythematosus, Sjogren‘s syndrome, and myositis.Geriatrics60, 32–38(2005).
  • Al-Hashimi I , KhuderS, HaghighatN, ZippM: Frequency and predictive value of the clinical manifestations in Sjögren‘s syndrome.J. Oral Pathol. Med.30, 1–6(2001).
  • Sjögren H : Some aspects on the Sicca syndrome.Scand. J. Rheumatol.2, 49–51(1973).
  • Manthorpe R , AsmussenK, OxholmP: Primary Sjögren‘s syndrome: diagnostic criteria, clinical features, and disease activity.J. Rheumatol.24(Suppl. 50), 8–11(1997).
  • Kassan SS , ThomasTL, MoutsopoulosHMet al.: Increased risk of lymphoma in Sicca syndrome.Ann. Intern. Med.89, 888–892(1978).
  • Valensini G , PrioriR, BavoillotDet al.: Differential risk of non-Hodgkin‘s lymphoma in Italian patients with primary Sjögren‘s syndrome.J. Rheumatol.24, 2376–2380(1997).
  • Kassan SS , MoutsopoulosHM: Clinical manifestations and early diagnosis of Sjogren syndrome.Arch. Intern. Med.174(12), 1275–1284(2004).
  • Al-Hashimi I : Recognition and treatment of Sjögren‘s syndrome, a multisystem disorder.Fam. Pract.25, 35–48(2003).
  • Nagler RM : Salivary glands and the aging process: mechanistic aspects, health-status and medicinal-efficacy monitoring.Biogerontology5(4), 223–233(2004).
  • Cassolato SF , TurnbullRS: Xerostomia: clinical aspects and treatment.Gerodontology20(2), 64–77(2003).
  • Sanchez-Guerrero J , Perez-DosalMR, Cardenas-VelazquezFet al.: Prevalence of Sjögren‘s syndrome in ambulatory patients according to the American–European Consensus Group criteria.Rheumatol. (Oxford)44(2), 235–240(2005).
  • Alamanos Y , TsifetakiN, VoulgariPVet al.: Epidemiology of primary Sjogren‘s syndrome in north-west Greece, 1982–2003.Rheumatol (Oxford)45(2), 187–191(2006).
  • Drosos AA , AndonopoulosAP, CostopoulosJSet al.: Prevalence of primary Sjogren‘s syndrome in an elderly population.Br. J. Rheumatol.27(2), 123–127(1988).
  • Scott J : Qualitative and quantitative observations on the histology of human labial salivary glands obtained post mortem.J. de Biologie Buccale8(3), 187–200(1980).
  • Scott J : Quantitative age changes in the histological structure of human submandibular salivary glands.Arch. Oral Biol.22, 221–227(1977).
  • Borchers AT , NaguwaSM, KeenCL, GershwinME: Immunopathogenesis of Sjogren‘s syndrome.Clin. Rev. Allergy Immunol.25(1), 89–104(2003).
  • Ittah M , Miceli-RichardC, GottenbergJEet al.: B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren‘s syndrome.Arthritis Res. Ther.8(2), R51 (2006).
  • Fauchais AL , BoumedieneA, LalloueFet al.: Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren‘s syndrome.Scand. J. Rheumatol.38(1), 50–57(2009).
  • Sakata K , SakataA, KongL, DangH, TalalN: Role of Fas/FasL interaction in physiology and pathology: the good and the bad.Clin. Immunol. Immunopathol.87, 1–7(1998).
  • Tzioufas AG , WassmuthR, DafniUGet al.: Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren‘s syndrome (pSS), a European multicentre study.Ann. Rheum. Dis.61, 398–404(2002).
  • Fox RI , MichelsonP: Approaches to the treatment of Sjögren‘s syndrome.J. Rheumatol.27(Suppl. 61), 15–21(2000).
  • Bacman S , PerezLC, Sterin-BoraLet al.: Autoantibodies against lacrimal gland M3 acetylcholine receptors in patients with primary Sjögren‘s syndrome.Invest. Ophthalmol. Vis. Sci.39, 151–156(1998).
  • Robinson CP , BrayerJ, YamachikaSet al.: Transfer of human serum IgG to nonobese diabetic Igµ null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren‘s syndrome.Proc. Natl Acad. Sci. USA95, 7538–7543(1998).
  • Waterman SA , GordonTP, RischmuellerM: Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren‘s syndrome.Arth. Rheum.43, 1747–1754(2000).
  • Fye KH , TerasakiPI, MoutsopoulosHMet al.: Association of Sjögren‘s syndrome with HLA-B8.Arth. Rheum.19, 883–886(1976).
  • Chused TM , KassanSS, OpelzG, MoutsopoulosHM, TerasakiPI: Sjögren‘s syndrome association with HLA-Dw3.N. Engl. J. Med.296, 895–897(1977).
  • Moutsopoulos HM , MannDL, JohnsonAH, ChusedTM: Genetic differences between primary and secondary sicca syndrome.N. Engl. J. Med.301, 761–763(1979).
  • Wilson RW , ProvostTT, BiasWBet al.: Sjögren‘s syndrome. Influence of multiple HLA-D region alloantigens on clinical and serologic expression:Arth. Rheum.27, 1245–1253(1984).
  • Kawakami A , NakashimaK, TamaiMet al.: Toll-like receptor in salivary glands from patients with Sjögren‘s syndrome: functional analysis by human salivary gland cell line.J. Rheumatol.34(5), 1019–1026(2007).
  • Spachidou MP , BourazopoulouE, MaratheftisCIet al.: Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjogren‘s syndrome.Clin. Exp. Immunol.147(3), 497–503(2007).
  • Fox RI : Sjögren‘s syndrome.Lancet366, 321–331(2005).
  • Yamazaki M , KitamuraR, KusanoSet al.: Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjogren‘s syndrome patients with pulmonary involvements.Clin. Exp. Immunol.139(3), 558–568(2005).
  • Scully C : Sjögren‘s syndrome: clinical and laboratory features immunopathogenesis, and management.Oral Surg. Oral Med. Oral. Pathol.62, 510–23 (1986).
  • Jorgensen C , LegouffeMC, PerneyPet al.: Sicca syndrome associated with hepatitis C virus infection.Arth. Rheum.39, 1176–1171(1996).
  • Fox RI , HowellFV, BoneRCet al.: Primary Sjögren syndrome: clinical and immunopathologic features.Semin. Arthritis Rheum.14, 77–105(1984).
  • Itescu S , WinchesterR: Diffuse infiltrative lymphocytosis syndrome: a disorder occurring in human immunodeficiency virus-1 infection that may present as a sicca syndrome.Rheum. Dis. Clin. North Am.18, 683–697(1992).
  • Cainelli F : Hepatitis C virus infection in the elderly epidemiology, natural history and management.Drugs Aging25(1), 9–18(2008).
  • Monteil RA , RaybaudH, Saint-PaulMCet al.: Comparative analysis of inflammation and fibrosis in the liver and salivary glands during chronic hepatitis.Oral Surg. Oral Med. Oral Path. Oral Radiol. Endod.91, 426–467(2001).
  • Ramos-Casals M , Garcia-CarrascoM, CerveraRet al.: Hepatitis C virus infection mimicking primary Sjögren‘s syndrome: a clinical and immunological description of 35 cases.Medicine80, 1–8(2001).
  • Siagris D , PharmakakisN, ChristofidouMet al.: Keratoconjunctivitis sicca and chronic HCV infection.Infection30(4), 229–233(2002).
  • De Vita S , DamatoR, De Marchi G, Sacco S, Ferraccioli G: True primary Sjögren‘s syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis. Isr. Med. Assoc. J.4(12), 1101–1105(2002).
  • Nagao Y , HanadaS, ShishidoSet al.: Incidence of Sjogren‘s syndrome in Japanese patients with hepatitis C virus infection.J. Gastroenterol. Hepatol.18(3), 258–266(2003).
  • Toussirot E , Le Huede G, Mougin C et al.: Presence of hepatitis C virus RNA in the salivary glands of patients with Sjogren‘s syndrome and hepatitis C virus infection. J. Rheumatol.29(11), 2382–2385(2002).
  • Sullivan DA : Sex hormones and Sjögren‘s syndrome.J. Rheumatol.24(Suppl. 50), 17–32(1997).
  • Sullivan DA , BélangerA, CermakJMet al.: Are women with Sjögren‘s syndrome androgen-deficient?J. Rheumatol.30, 2413–2419(2003).
  • Whitacre CC : Sex differences in autoimmune disease.Nat. Immunol.2, 777–780(2001).
  • Ishimaru N , ArarkakiR, OmoteharaFet al.: Novel role of RbAp48 for tissue specific estrogen deficiency-dependent apoptosis in the exocrine glands.Mol. Cell Biol.26, 2924–2935(2006).
  • Taiym S , HaghighatN, Al-HashimiI: A comparison of the hormone levels in patients with Sjögren‘s syndrome andhealthy controls.Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.97, 579–583(2004).
  • Deming FP , Al-HashimiI, HaghighatNet al.: Comparison of salivary calmodulin binding proteins in Sjögren‘s syndrome and healthy individuals.J. Oral Path. Med.36, 132–135(2007).
  • Haghighat N , Al-HashimiI: The status of lactoferrin and iron binding capacity of saliva in Sjögren‘s syndrome.Clin. Exp. Rheumatol.21, 485–488(2003).
  • Manthorpe R , Frost-LarsenK, IsagerH, PrauseJU: Sjögren‘s syndrome: a review with emphasis on immunological features.Allergy36, 139–153(1981).
  • Scully C : Sjögren‘s syndrome: clinical and laboratory features, immunopathogenesis, and management.Oral Surg. Oral Med. Oral Pathol.62, 510–523(1986).
  • Molina R , ProvostT, ArnettFCet al.: Primary Sjögren‘s syndrome in men.Am. J. Med.80, 23–31(1986).
  • Moutsopoulos HM , ChusedTM, MannDLet al.: Sjögren‘s syndrome (sicca syndrome): currentissues.Ann. Int. Med.92, 212–226(1980).
  • Bonafede RP , DowneyDC, BennettRM: An association of fibromyalgia with primary Sjögren‘s syndrome: a prospective study of 72 patients.J. Rheumatol.22, 133–136(1995).
  • Cimaz R , CasadeiA, RoseCet al.: Primary Sjogren syndrome in the paediatric age: a multicentre survey.Eur. J. Paediatr.172(10), 661–665(2003).
  • Ramos-Casals M , CerveraR, FontJet al.: Young onset of primary Sjögren‘s syndrome: clinical and immunological characteristics.Lupus7, 202–206(1998).
  • Haga HJ , JonssonR: The influence of age on disease manifestations and serological characteristics in primary Sjögren‘s syndrome.Scand. J. Rheumatol.28(4), 227–232(1999).
  • Daniels TE , WhitcherJP: Association of patterns of labial salivary gland inflammation with keratoconjuctivitis sicca. Analysis of 618 patients with suspected Sjögren‘s syndrome.Arth. Rheum.37, 869–877(1994).
  • Rhodus NL , ColbyS, MollerK, BereuterJ: Quantitative assessment of dysphagia in patients with primary and secondary Sjögren‘s syndrome.Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.79, 305–310(1995).
  • Mandel ID : The functions of saliva.J. Dent. Res.66, 623–627(1987).
  • Dusek M , SimmonsJ, BuschangPH, Al-HashimiI: Masticatory function in patients with xerostomia.Gerodontol.13, 3–6(1996).
  • Manoussakis MN , MoutsopoulosHM: Sjögren‘s syndrome.Otolaryngol. Clin. North Am.32, 843–860(1999).
  • Bloch KJ , BuchananWW, WohlMJ, BunimJJ: Sjögren‘s syndrome: A clinical, pathological, and serological study of sixty-two cases.Medicine44, 187–231(1965).
  • Abraham CM , Al-HashimiI, HaghighatN: Evaluation of the levels of oral Candida in patients with Sjögren‘s syndrome.Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.86, 65–68(1998).
  • Hernandez YL , DanielsTE: Oral candidiasis in Sjögren‘s syndrome: prevalence, clinical correlations, and treatment.Oral Surg. Med. Oral Pathol.68, 324–329(1989).
  • Price EJ , VenablesPJ: Dry eyes and mouth syndrome: a subgroup of patients presenting with sicca symptoms.Rheumatol. (Oxford)41(4), 417–422(2002).
  • Ostuni PA , GermanaB, DiMarioFet al.: Gastric involvement in primary Sjögren‘s syndrome.Clin. Exp. Rheumatol.11, 21–25(1993).
  • Mandl T , EkbergO, WollmerP, ManthorpeR, JacobssonLT: Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sjogren‘s syndrome.Scand. J. Rheumatol.36(5), 394–401(2007).
  • Trevino H , TsianosEB, SchenkerS: Gastrointestinal and hepatobiliary features in Sjögren‘s syndrome. In: Sjögren‘s Syndrome. Clinical and Immunopathologic Aspects. Talal N, Moutsopoulos HM, Kassan SS (Eds). Springer-Verlag, Berlin, Germany, 89–95 (1987).
  • Volter F , FainO, MathieuEet al.: Esophageal function and Sjögren‘s syndrome.Dig. Dis. Sci.49, 248–253(2004).
  • Constantopoulos SH , TsianosEV, MoutsopoulosHM: Pulmonary and gastrointestinal manifestations of Sögren‘s syndrome.Rheum. Dis. Clin. North Am.18, 617–635(1992).
  • Schneider A , MerikhiA, FrankBB: Autoimmune disorders: gastrointestinal manifestations and endoscopic findings.Gastrointest. Endoscopy Clin. N. Am.17, 133–151(2006).
  • Masaki Y , SugaiS: Lymphoproliferative disorders in Sjögren‘s syndrome.Autoimmun. Rev.3, 175–182(2004).
  • Skopouli FN , BarbatisC, MoutsopoulosHM: Liver involvement in primary Sjögren‘s syndrome.Br. J. Rheumatol.33, 745–748(1994).
  • Kaplan MJ , IkeRW: The liver is a common non-exocrine target in primary Sjogren‘s syndrome: a retrospective review.BMC Gastroenterol.2(1), 21 (2002).
  • Csepregi A , SzdorayP, ZeherM: Do autoantibodies predict autoimmune liver disease in primary Sjögren‘s syndrome? Data of 180 patients upon a 5-year follow-up.Scand. J. Immunol.56, 623–629(2002).
  • Lindgren S , ManthorpeR, ErikssonS: Autoimmune liver disease in patients with primary Sjögren‘s syndrome.J. Hepatol.20, 354–358(1994).
  • Montefusco PP , GeissAC, BronzoRLet al.: Sclerosing cholangitis, chronic pancreatitis, and Sjögren‘s syndrome: a syndrome complex.Am. J. Surg.147, 822–826(1984).
  • Fenster LF , BuchananWW, LasterL, BunimJJ: Studies of pancreatic function in Sjögren‘s syndrome.Ann. Intern. Med.61, 498–508(1964).
  • Cardell BS , GurlingKJ: Observations on the pathology of Sjögren‘s syndrome.J. Pathol. Bacteriol.68, 137–146(1954).
  • Bucher UG , ReidL: Sjögren‘s syndrome. Report of a fatal case with pulmonary and renal lesions.Br. J. Dis. Chest53, 237–252(1959).
  • Matsuda M , HamanoH, YoshidaTet al.: Seronegative Sjögren syndrome with a symptomatic autoimmune sclerosing pancreatitis. Case report.Clin. Rheumatol.26, 117–119(2007).
  • Kino-Ohsaki J , NishimoriI, Morita Met al.: Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren‘s syndrome. Gastroenterol.110, 1054–1056(1996).
  • Strimlan CV , RosenowEC 3rd, Divertie MB, Harrison EG Jr: Pulmonary manifestations of Sjögren‘s syndrome. Chest70, 354–361(1976).
  • Hunninghake GW , FauciAS: Pulmonary involvement in the collagen vascular diseases.Am. Rev. Resp. Dis.119, 471–503(1979).
  • Fairfax AJ , HaslamPL, PaviaDet al.: Pulmonary disorders associated with Sjögren‘s syndrome.Q. J. Med.50, 279–295(1981).
  • Constantopoulos SH , PapadimitriouCS, MoutsopoulosHM: Respiratory manifestations in primary Sjögren‘s syndrome. A clinical, functional, and histologic study.Chest88, 226–229(1985).
  • Kelly C , GardinerP, PatB, GriffithsI: Lung function in primary Sjögren‘s syndrome: a cross sectional and longitudinal study.Thorax46, 180–183(1991).
  • Constantopoulos SH , MoutsopoulosHM: The respiratory system in Sjögren‘s syndrome. In: Sjögren‘s syndrome. Clinical and Immunopathologic aspects. Talal N, Moutsopoulos HM, Kassan SS (Eds). Springer-Verlag, Berlin, Germany, 83–88(1987).
  • Hansen LA , PrakashUB, ColbyTV: Pulmonary lymphoma in Sjögren‘ssyndrome.Mayo Clin. Proc.64, 920–931(1989).
  • Kamholz S , SherA, BarlandPet al.: Sjögren‘s syndrome: severe upper airways obstruction due to primary malignant tracheal lymphoma developing during successful treatment of lymphocytic interstitial pneumonitis.J. Rheumatol.14, 588–594(1987).
  • Kadota J -I, Kusano S, Kawakami K, Morikawa T, Kohno S: Usual interstitial pneumonia associated with primary Sjögren‘s syndrome. Chest108, 1756–1758(1995).
  • Gardiner P , WardC, AllisonAet al.: Pleuropulmonary abnormalities in primary Sjögren‘s syndrome.J. Rheumatol.20, 831–837(1993).
  • Robinson DA , MeyerCF: Primary Sjögren‘s syndrome associated with recurrent sinopulmonary infections and bronchiectasis.J. Allergy Clin. Immunol.945, 263–264(1994).
  • Hedgpeth MD , BoulwareDW: Pulmonary hypertension in primary Sjögren‘s syndrome.Ann. Rheum. Dis.47, 251–253(1988).
  • McMahon MJ , SwinsonDR, Shettar Set al.: Bronchiectasis and rheumatoid arthritis: a clinical study. Ann. Rheum. Dis.52, 776–779(1993).
  • Begin R , MasseS, CantinA, MenardHA, BureauMA: Airway disease in a subset of nonsmoking rheumatoid patients. Characterization of the disease and evidence for an autoimmune pathogenesis.Am. J. Med.72, 743–750(1982).
  • Radoux V , MenardHA, BeginR, DecaryF, KoopmanWJ: Airways disease in rheumatoid arthritis patients. One element of a general exocrine dysfunction.Arth. Rheum.30, 249–256(1987).
  • Kamholz S , SherA, BarlandPet al.: Sjögren‘s syndrome: severe upper airway obstruction due to malignant lymphoma developing during successful treatment of lymphocytic interstitial pneumonia.J. Rheumatol.14, 588–594(1987).
  • Kita T , FujimuraM, HayaseM, MatsudaT, NonomuraA: Pulmonary non-Hodgkin‘s lymphoma that arose in mucosa-associated lymphomoid tissue of the salivary gland and was diagnosed at autopsy.Nippon Kyobu Shikkan Gakkai Zasshi33, 1119–1124(1995).
  • Tumiati B , CasoliP, ParmeggianiA: Hearing loss in the Sjögren syndrome.Ann. Intern. Med.126, 450–453(1997).
  • Konttinen YT , RamsayH, HietanenJ, SorsaT, NordstromD: Otitis externa sicca/fibrotizing external otitis (FEO) as a complication of Sjögren‘s syndrome.Clin. Exp. Rheumatol.18, 746–748(2000).
  • Haga HJ , GjesdalCG, IrgensLMet al.: Reproduction and gynaecological manifestations in women with primary Sjögren syndrome: a case–control study.Scand. J. Rheumatol.34(1), 45–48(2005).
  • Tishler M , CaspiD, AlmogY, SegalR, YarnoM: Increased incidence of urinary tract infection in patients with rheumatoid arthritis and secondary Sjögren‘s syndrome.Ann. Rheum. Dis.51, 604–606(1992).
  • Soy M , PiskinS: Cutaneous findings in patients with primary Sjögren syndrome.Clin. Rheumatol.26(8), 1350–1352(2006).
  • Bernacchi E , AmatoL, ParodiAet al.: Sjogren‘s syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology.Clin. Exp. Rheumatol.22(1), 55–62(2004).
  • Anaya J -M, Talal N: Sjögren‘s syndrome. In: Current Therapy in Adult Medicine 4th Edition. Kassirer JP, Greene HL (Eds). Mosby, MO, USA 1291–1298(1997).
  • Ostuni P , BotsiosC, SfrisoPet al.: Fibromyalgia in Italian patients with primary Sjögren‘s syndrome.Joint Bone Spine69, 51–57(2002).
  • Ramos-Casals M , AnayaJM, Garcia-CarrascoMet al.: Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients.Medicine83(2), 96–106(2004).
  • Fox RI , SternM, MichelsonP: Update in Sjögren syndrome.Curr. Opin. Rheumatol.12, 391–398(2000).
  • de Winter S , van Buchem MA, Vermeer MH: Annular erythema of Sjögren‘s syndrome. Lancet367, 1704 (2006).
  • Skopouli FN , TalalA, GalanopoulouVet al.: Raynaud‘s phenomenon in primary Sjögren‘s syndrome.J. Rheumatol.17, 618–620(1990).
  • Kassan SS , TalalN: Renal disease with Sjögren‘s syndrome. In: Sjögren‘s Syndrome. Clinical and Immunopathologic Aspects. Talal N, Moutsopoulos HM, Kassan SS(Eds). Springer-Verlag, Berlin, Germany, 96–101(1987).
  • Moutsopoulos HM , CledesJ, SkopouliFN, ElisafM, YouinouP: Nephrocalcinosis in Sjögren‘s syndrome: a late sequela of renal tubular acidosis.J. Intern. Med.230, 187–191(1991).
  • Moutsopoulos HM , BalowJE, LawleyTJet al.: Immune complex glomerulonephritis in sicca syndrome.Am. J. Med.64, 955–960(1978).
  • Hansen BU , EricssonUB, HenricssonV, LarssonA: Autoimmune thyroiditis and primary Sjögren‘s syndrome: clinical and laboratory evidence of the coexistence of the diseases.Clin. Exp. Rheumatol.9, 137–141(1991).
  • Ichikawa Y , FukudaR: Clinical and pathological features of Sjögren‘s syndrome associated with autoimmune thyroid disease.Nippon Rinsho53, 2545–2550(1995).
  • Coll J , AngladaJ, ThomasSet al.: High prevalence of subclinical Sjögren‘s syndrome features in patients with autoimmune thyroid disease.J. Rheumatol.24, 1719–1724(1997).
  • Karsh J , PavidisN, WeintraubBD, MoutsopoulosHM: Thyroid disease in Sjögren‘s syndrome.Arth. Rheum.23, 1326–1329(1980).
  • Loviselli A , MathieuA, PalaRet al.: Development of thyroid disease in patients with primary and secondary Sjögren‘s syndrome.J. Endocrinol. Invest.11, 653–656(1988).
  • Scofield RH : Autoimmune thyroid disease in systemic lupus eythematosus and Sjögren‘s syndrome.Clin. Exp. Rheumatol.14, 321–330(1996).
  • Lundstrom IM , LindstromFD: Iron and vitamin deficiencies, endocrine and immune status in patients with primary Sjögren‘s syndrome.Oral. Dis.7, 144–149(2001).
  • Kamilaris TC , DeBoldCR, JohnsonEOet al.: Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone responses to bovine corticotropin-releasing hormone in rats.Endocrinology128, 2567–2576(1991).
  • Johnson EO , VlachoyiannopoulosPG, SkopouliFN, TzioufasAG, MoutsopolousHM: Hypofunction of the stress axis in Sjögren‘s syndrome.J. Rheumatol.25, 1508–1514(1998).
  • Jara LJ , LavalleC, FragaAet al.: Prolactin, immunoregulation, and autoimmune diseases.Semin. Arth. Rheum.20, 273–284(1991).
  • Masi AT , ChattertonRT, AldagJC: Perturbations of hypothalamic-pituitary-gonadal axis and adrenal androgen functions in rheumatoid arthritis: an odyssey of hormonal relationships to the disease.Ann. NY Acad. Sci.876, 53–62(1999).
  • Molina R , ProvostTT, ArnettFCet al.: Primary Sjögren‘s syndrome in men. Clinical, serologic, and immunogenetic features.Am. J. Med.80, 23–31(1988).
  • Goransson LG , HerigstadA, TjensvollABet al.: Peripheral neuropathy in primary Sjögren syndrome: a population-based study.Arch. Neurol.63(11), 1712–1715(2006).
  • Lopate G , PestronkA, Al-LoziMet al.: Peripheral neuropathy in an outpatient cohort of patients with Sjogren‘s syndrome.Muscle Nerve33(5), 672–676(2006).
  • Lafitte C : Neuroradiological manifestations of primary Sjögren‘s syndrome.Rev. Neurol. (Paris)158(10 pt 1), 959–965(2002).
  • Andonopoulos AP , LagosG, DrososAA, MoutsopoulosHM: The spectrum of neurological involvement in Sjögren‘s syndrome.Br. J. Rheumatol.29, 21–23(1990).
  • Alexander EL , MalinowK, LejewskiJEet al.: Primary Sjögren‘s syndrome with central nervous system disease mimicking multiple sclerosis.Ann. Intern. Med.104, 323–330(1986).
  • Binder A , SnaithML, IsenbergD: Sjogren‘s syndrome: a study of its neurological complications.Br. J. Rheumatol.27(4), 275–280(1988).
  • Govoni M , PadovanM, RizzoNet al.: Neurological involvement in primary Sjogren‘s syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach.CNS Drugs15(8), 597–607(2001).
  • Lafitte C , AmouraZ, CacoubPet al.: Neurological complications of primary Sjogren‘s syndrome.J. Neurol.248(7), 577–584(2001).
  • Noseworthy JH , BassBH, VandervoortMKet al.: The prevalence of primary Sjögren‘s syndrome in a multiple sclerosis population.Ann. Neurol.25, 95–98(1989).
  • Vincent TL , RichardsonMP, MackworthCG, HawkeSH, VenablesPJW: Sjögren‘s syndrome-associated myelopathy: response to immunosuppressive treatment.Am. J. Med.114, 145–148(2003).
  • Andonopoulos AP , ChristodoulouJ, BallasCet al.: Autonomic cardiovascular neuropathy in Sjögren‘s syndrome: a controlled study.J. Rheumatol.25(12), 2385–2388(1998).
  • Utset TO , GoldenM, SiberryG, KiriN, GrumRM, PetriM: Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjögren‘s syndrome.J. Rheumatol.21, 2039–2045(1994).
  • Thomas E , HayEM, HajeerA, SilmanAJ: Sjögren‘s syndrome: a community-based study of prevalence and impact.Br. J. Rheumatol.37, 1069–1076(1998).
  • Malinow KL , MolinaR, GordonBet al.: Neuropsychiatric dysfunction in primary Sjögren‘s syndrome.Ann. Intern. Med.103, 344–350(1985).
  • Valtysdottir ST , GudbjörnssonB, LindqvistU, HallgrenR, HettaJ: Anxiety and depression in patients with primary Sjögren‘s syndrome.J. Rheumatol.27, 175–179(2000).
  • Kauppi M , PukkalaE, IsomäkiH: Elevated incidence of hematologic malignancies in patients with Sjögren‘s syndrome compared with patients with rheumatoid arthritis (Finland).Cancer Causes Control8, 201–204(1997).
  • Ioannidis JP , VassiliouVA, MoutsopoulosHM: Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren‘s syndrome.Arth. Rheum.46, 741–747(2002).
  • Kordossis T , PaikosS, Aronika et al.: Prevalence of Sjögren‘s-like syndrome in a cohort of HIV-1-positive patients: descriptive pathology and immunology. Br. J. Rheumatol.37, 691–695(1998).
  • Lamey P -J, Lundy F, Al-Hashimi I: Primary and secondary Sjögren‘s syndrome: Conditions with features of graft versus host disease and altered duct cell permeability. Medical Hypotheses62, 825–829(2004).
  • Richey TK , BennionSD: Etiologies of the sicca syndrome: primary systemic amyloidosis and others.Int. J. Dermatol.35, 553–557(1996).
  • Al-Hashimi I , DrinnanAA, WrightJR, LevineMJ: Oral amyloidosis: two unusual case presentations.Oral Surg. Oral Med. Oral Pathol.63, 586–591(1987).
  • Sack KE , WhitcherJP, CartertonNL, GreenspanJS, DanielsTE: Sarcoidosis mimicking Sjögren‘s syndrome: histopathologic observations.J. Clin. Rheumatol.4, 13–17(1998).
  • Drosus AA , ConstantopoulosSH, PsychosDet al.: The forgotten cause of sicca complex: sarcoidosis.J. Rheumatol.17, 1548–1551(1989).
  • Mansour MJ , Al-HashimiI, WrightJM: Coexistence of sarcoidosis and Sjögren‘s syndrome: a report of 5 cases.J. Oral Path. Med.36, 337–341(2007).
  • Sreebny LM , YuA, GreenA, ValdiniA: Xerostomia in diabetes mellitus.Diabetes Care15, 900–904(1992).
  • Chavez EM , TaylorGW, BorrellLN, ShipJA: Salivary function and glycemic control in older persons with diabetes.Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.89, 305–311(2000).
  • Simmons DD , Al-HashimiI, HaghighatN: Effect of xerostomic medications on stimulated salivary flow rate in patients with Sjögren‘s syndrome.Quintessence Int.31, 196–200(2000).
  • Vitali C , BombardieriS, JonssonRet al.: Classification criteria for Sjögren‘s syndrome: a revised versions of the European criteria proposed by the American–European Consensus Group.Ann. Rheum. Dis.61, 554–558(2002).
  • Vitali C , BombardieriS, MoutsopoulosMMet al.: Preliminary criteria for the classification of Sjögren‘s syndrome: results of a prospective concerted action supported by the European community.Arth. Rheum.36, 340–347(1993).
  • Manthorpe R : Classification criteria for Sjögren‘s syndrome. Author‘s response.Ann. Rheum. Dis.62, 95 (2003).
  • Vitali C : Classification criteria for Sjögren‘s syndrome.Ann. Rheum. Dis.62, 94–95(2003).
  • Bell M , AskariA, FrydrychSet al.: Sjögren‘s syndrome: a critical review of clinical management.J. Rheumatol.26, 2051–2061(1999).
  • de Seze J , DevosD, CastelnovoGet al.: The prevalence of Sjögren syndrome in patients with primary progressive multiple sclerosis.Neurology57, 1359–1363(2001).
  • Thong BY , VenketasubramanianN: A case of Sjögren‘s syndrome or multiple sclerosis? A diagnostic and therapeutic dilemma.Rheumatol. Int.22, 256–258(2002).
  • Ship JA , FoxPC, BaumBJ: How much saliva is enough? ‘Normal’ function defined.J. Am. Dent. Assoc.122, 63–69(1991).
  • Rubin H , HoltM: Secretory sialogram in diseases of the major salivary glands.Am. J. Roentgenol.77, 575–598(1957).
  • Dijkstra PF : Classification and differential diagnosis of sialographic characteristics in Sjögren syndrome.Semin. Arth. Rheum.10, 10–17(1980).
  • Umehara I , YamadaI, MurataY, TakehashiY, OkadaN, ShibuyaH: Quantitative evaluation of salivary gland scintigraphy in Sjögren‘s syndrome.J. Nucl. Med.40, 64–69(1999).
  • Aung W , YamadaI, UmeharaI, OhbayashiN, YoshinoN, ShibuyaH: Sjögren‘s syndrome: comparison of assessments with quantitative salivary gland scintigraphy and contrast sialography.J. Nucl. Med.41, 257–262(2000).
  • Schall GL , AndersonLG, WolfROet al.: Xerostomia in Sjögren‘s syndrome: evaluation by sequential salivary scintigraphy.J. Am. Med. Assoc.217, 2109–2117(1971).
  • Al-Hashimi I , HaghighatN, FoxPC: Salivary electrophoresis in the diagnosis of SS.Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.85, 542–547(1998).
  • Makula E , PokornyG, KissMet al.: The place of magnetic resonance and ultrasonographic examinations of the parotid gland in the diagnosis and follow-up of primary Sjögren‘s syndrome.Rheumatology (Oxford)39, 97–104(2000).
  • Lamey P -J, Biagioni PA, Al-Hashimi I: The feasibility of infrared thermography in the evaluation of the oral mucosal wetness: a pilot study. J. Oral Path. Med.36, 127–131(2007).
  • Murube J , NemethJ, HöhHet al.: The triple classification of dry eye for practical clinical use.Eur. J. Ophthal.15, 660–667(2005).
  • Vivino FB , Al-HashimiI, KhanZet al.: Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome.Arch. Intern. Med.159, 174–181(1999).
  • Petrone D , CondemiJJ, FifeR, GluckO, CohenS, DalginP: A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren‘s syndrome patients with xerostomia and keratoconjunctivitis sicca.Arth. Rheum.46, 748–754(2002).
  • Weber J , KeatingGM: Cevimeline.Drugs68(12), 1791–1798(2008).
  • Al-Hashimi I : Xerostomia secondary to Sjögren‘s syndrome in the elderly: recognition and management.Drugs Aging22, 887–899(2005).
  • Ship JA , FoxPC, MichalekJEet al.: Treatment of primary, Sjögren‘s syndrome with low-dose natural human interferon administered, by the oral mucosal route: a Phase II clinical trial.J. Interferon. Cytokine Res.19, 943–951 (1999).
  • Cotrim AP , MineshibaF, SugitoT, SamuniY, BaumBJ: Salivary gland gene therapy.Dent. Clin. N. Am.50, 157–173(2006).
  • Pflugfelder SC : Anti-inflammatory therapy for dry eye.Am. J. Ophthalmol.137(2), 337–342(2004).
  • Fox RI , ChanE, BentonL, FongS, FriedlanderM, HowellFV: Treatment of primary Sjögren‘s syndrome with hydroxychloroquine.Am. J. Med.85, 62–67(1988).
  • Fox RI : Sjögren‘s syndrome: evolving therapies.Expert Opin. Investig. Drugs12, 247–254(2003).
  • Steinfeld SD , DemolsP, SalmonI, KissR, AppelboomT: Infliximab in patients with primary Sjögren‘s syndrome: a pilot study.Arth. Rheum.44, 2371–2375(2001).
  • Mariette X , RavaudP, SteinfeldSet al.: Inefficacy of infliximab in primary Sjögren‘s syndrome: results of the randomized, controlled trial of Remicade® in primary Sjögren‘s syndrome.Arth. Rheum.50, 4077–4078(2004).
  • Boillée S , ClevelandDW: Gene therapy for ALS delivers.Trends Neurosciences27, 235–238(2004).
  • Al-Hashimi I : Sjögren‘s syndrome: diagnosis and management.Womens Health (Lond Engl).3(1), 107–122(2007).
  • Ekström SK , VajdicCM, FalsterMet al.: Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the Inter Lymph Consortium.Blood111(8), 4029–4038(2008).
  • Ekström S medby K: Risk of non-Hodgkin lymphoma and identification of specific subtypes in NHL in Sjögren‘s syndrome. Sjögren‘s Quarterly3(2), 1 (2008).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.